News As Brexit trigger nears, UK pharma prepares for different sc... AstraZeneca chief considers two possible scenarios for post-Brexit regulation
News Prime minister accused of being "in denial" about NHS crisis PM under fire over A&E waiting times.
Views & Analysis ‘Quickie divorce’ Brexit not an option for medicines, says U... The UK government wants a 'bespoke' deal for pharma - but the EU has other ideas.
News UK could seek ‘transitional deal’ to cushion Brexit PM also promises corporation tax cuts and innovation investment
Views & Analysis What doctors say about Theresa May’s reappointment of Jeremy... Reactions of healthcare professionals to Jeremy Hunt staying as Health Secretary.
News Lexicon's type 1 diabetes drug voted down by FDA adcomm It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.